Literature DB >> 31353640

The effects of hesperidin on sodium arsenite-induced different organ toxicity in rats on metabolic enzymes as antidiabetic and anticholinergics potentials: A biochemical approach.

Cuneyt Caglayan1, Yeliz Demir2, Sefa Kucukler3, Parham Taslimi2, Fatih Mehmet Kandemir3, İlhami Gulçin2.   

Abstract

In our work, it was purposed to investigate the effects of sodium arsenite (SA) and hesperidin (HSP) administered to rats on some metabolic enzymes including carbonic anhydrase (CA), aldose reductase (AR), paraoxonase-1 (PON1), α-glycosidase (α-Gly), butyrylcholine esterase (BChE), acetylcholine esterase (AChE) enzymes activities in the brain, heart, liver, testis, and kidney tissues of rats. CA activities were significantly decreased in testis, liver, and heart tissues of rats given HSP, SA, SA+HSP-100, and SA+HSP-200 compared to control (p < 0.05). In liver tissue, AChE and BChE enzymes activities were significantly reduced given in all groups. In all tissues, α-Gly activity was reduced given in all groups. In the current study, aldose reductase enzyme activity was reduced significantly in testis, brain, and heart tissues of all groups compared to standard (p < 0.05). PON1 enzyme activity was increased significantly in kidney and liver tissues of rats HSP groups and decreased SA groups compared to control. PRACTICAL APPLICATIONS: α-Glycosidase is the key enzyme involved in the digestion of the carbohydrate. Another enzyme α-amylase hydrolyzes the α-linked polysaccharide derivatives into oligosaccharide molecules, and α-glycosidase enzymes, which are characterized in small intestine, catalyze the final stage in the digestive mechanism of carbohydrate molecule to release absorbable monosaccharides like glucose. Conforming to the cholinergic hypothesis, impairment of the cholinergic pathways plays a good role in the development of neurodegenerative diseases like depression, schizophrenia, Alzheimer's disease (AD) problems with the regulation of traumatic brain injury and sleep. The AD is the main reason for dementia disease, and mild to moderate cases are generally treated with AChE inhibitors. Human CA inhibitor compounds are clinically used for more than 70 years as antiglaucoma and diuretics drugs.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  hesperidin; in vivo; metabolic enzymes; rats; sodium arsenite

Mesh:

Substances:

Year:  2018        PMID: 31353640     DOI: 10.1111/jfbc.12720

Source DB:  PubMed          Journal:  J Food Biochem        ISSN: 0145-8884            Impact factor:   2.720


  5 in total

1.  Inhibition effects of some pesticides and heavy metals on carbonic anhydrase enzyme activity purified from horse mackerel (Trachurus trachurus) gill tissues.

Authors:  Cuneyt Caglayan; Parham Taslimi; Cebrahil Türk; İlhami Gulcin; Fatih Mehmet Kandemir; Yeliz Demir; Şükrü Beydemir
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-15       Impact factor: 4.223

2.  Hesperidin Attenuates Oxidative Stress, Inflammation, Apoptosis, and Cardiac Dysfunction in Sodium Fluoride-Induced Cardiotoxicity in Rats.

Authors:  Behçet Varışlı; Ekrem Darendelioğlu; Cuneyt Caglayan; Fatih Mehmet Kandemir; Adnan Ayna; Aydın Genç; Özge Kandemir
Journal:  Cardiovasc Toxicol       Date:  2022-05-23       Impact factor: 2.755

Review 3.  Bioavailability of Hesperidin and Its Aglycone Hesperetin-Compounds Found in Citrus Fruits as a Parameter Conditioning the Pro-Health Potential (Neuroprotective and Antidiabetic Activity)-Mini-Review.

Authors:  Kamil Wdowiak; Jarosław Walkowiak; Robert Pietrzak; Aleksandra Bazan-Woźniak; Judyta Cielecka-Piontek
Journal:  Nutrients       Date:  2022-06-26       Impact factor: 6.706

Review 4.  Physiological and Pathological Roles of Aldose Reductase.

Authors:  Mahavir Singh; Aniruddh Kapoor; Aruni Bhatnagar
Journal:  Metabolites       Date:  2021-09-27

5.  The palladium-based complexes bearing 1,3-dibenzylbenzimidazolium with morpholine, triphenylphosphine, and pyridine derivate ligands: synthesis, characterization, structure and enzyme inhibitions.

Authors:  Aydın Aktaş; Gül Yakalı; Yeliz Demir; İlhami Gülçin; Muhittin Aygün; Yetkin Gök
Journal:  Heliyon       Date:  2022-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.